Contribute Try STAT+ Today

The hiring of Jack Stoddard brings a veteran business mind into the effort to shake up the U.S. health care system by Amazon, Berkshire Hathaway, and JPMorgan Chase — an entrepreneur with a track record of using digital tools to change the way services are delivered to patients while saving money.

Stoddard, the Boston-based venture’s new chief operating officer, has worked in health care for 25 years, spending much of that time building companies focused on using data and technology to guide patients to the most appropriate and cost-effective care. Most recently, he led the reshaping of health benefits at Comcast Corp.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • Why do I have to try a 30 day subscription to STAT when all I wanted to do was read the full article which I am entitled to with a Boston Globe account? You need to change this.

  • Why must I sigh into STAT NEWS when I have a Boston Globe account? Very user unfriendly to have to sign in again!!!

Comments are closed.